Alteogen (KRX: 196170)
Who is buying Alteogen?
Between Sep 10, 2026 and Oct 13, 2026 (20 trading sessions), foreign investors net bought ₩114.1bn ($86M) of Alteogen, the 4th largest foreign net purchase among 1828 KOSDAQ stocks. Institutions net sold ₩73.9bn ($55M) and retail investors net sold ₩33.1bn ($25M) over the same window. Foreigners were net buyers on 12 of the 20 sessions.
Foreign investors hold 15.96% of Alteogen's listed shares (KRX ownership data as of Oct 13, 2026), up from 14.69% twenty sessions earlier and 13.35% a year ago.
The stock closed at ₩224,500 on Oct 13, 2026: -19.68% over 20 sessions, -35.09% year-to-date, -34.29% over one year. The 52-week range is ₩194,671 – ₩437,818.
At ₩224,500 the stock trades at 43.30× 12-month-forward consensus earnings (6 analysts), 41.55× on FY2027 estimates. The trailing P/E published by KRX is 110.00×, based on the last completed fiscal year — the gap reflects earnings expected to rise sharply from last year's level.
View chart data as a table
| Date | Close | Foreign net | Institutions | Retail |
|---|---|---|---|---|
| 2026-10-13 | ₩224,500 | +₩26.0bn | +₩7.5bn | ₩-34.5bn |
| 2026-10-12 | ₩231,500 | +₩28.5bn | ₩-10.7bn | ₩-17.0bn |
| 2026-10-08 | ₩241,000 | +₩6.7bn | +₩9.3bn | ₩-14.8bn |
| 2026-10-07 | ₩257,000 | ₩-14.9bn | ₩-3.3bn | +₩17.8bn |
| 2026-10-06 | ₩260,000 | ₩-3.7bn | ₩-10.8bn | +₩13.9bn |
| 2026-10-02 | ₩259,500 | ₩-16.5bn | ₩-7.9bn | +₩23.7bn |
| 2026-10-01 | ₩265,000 | +₩7.3bn | +₩39.5bn | ₩-46.6bn |
| 2026-09-30 | ₩254,500 | +₩17.2bn | +₩4.4bn | ₩-20.8bn |
| 2026-09-29 | ₩253,500 | +₩3.2bn | +₩8.4bn | ₩-11.5bn |
| 2026-09-28 | ₩252,500 | ₩-2.4bn | +₩9.4bn | ₩-6.5bn |
| 2026-09-23 | ₩250,000 | +₩5.4bn | ₩-3.7bn | ₩-1.8bn |
| 2026-09-22 | ₩249,500 | ₩-6.4bn | ₩-12.9bn | +₩18.8bn |
| 2026-09-21 | ₩255,000 | ₩-2.7bn | +₩2.8bn | +₩0.7bn |
| 2026-09-18 | ₩253,500 | ₩-7.3bn | ₩-0.6bn | +₩6.4bn |
| 2026-09-17 | ₩254,000 | ₩-4.9bn | ₩-9.0bn | +₩14.0bn |
| 2026-09-16 | ₩255,500 | +₩0.4bn | ₩-3.9bn | +₩4.2bn |
| 2026-09-15 | ₩260,000 | +₩6.4bn | +₩3.5bn | ₩-9.5bn |
| 2026-09-14 | ₩260,000 | +₩36.0bn | ₩-23.9bn | ₩-8.5bn |
| 2026-09-11 | ₩268,000 | +₩9.6bn | ₩-48.8bn | +₩41.5bn |
| 2026-09-10 | ₩277,000 | +₩26.1bn | ₩-23.1bn | ₩-2.7bn |
| 2026-09-09 | ₩279,500 | +₩44.5bn | ₩-0.4bn | ₩-43.4bn |
| 2026-09-08 | ₩277,000 | +₩10.4bn | ₩-41.5bn | +₩33.6bn |
| 2026-09-07 | ₩286,000 | +₩2.2bn | ₩-22.9bn | +₩22.3bn |
| 2026-09-04 | ₩288,500 | +₩38.4bn | +₩15.8bn | ₩-53.3bn |
| 2026-09-03 | ₩283,000 | ₩-83.9bn | ₩-63.8bn | +₩164.8bn |
| 2026-09-02 | ₩298,500 | ₩-105.3bn | ₩-53.1bn | +₩168.8bn |
| 2026-09-01 | ₩301,000 | +₩7.9bn | ₩-24.9bn | +₩16.8bn |
| 2026-08-31 | ₩307,500 | ₩-58.7bn | ₩-7.7bn | +₩65.6bn |
| 2026-08-28 | ₩320,000 | +₩37.1bn | +₩31.3bn | ₩-70.0bn |
| 2026-08-27 | ₩311,500 | +₩16.1bn | +₩3.7bn | ₩-18.6bn |
| 2026-08-26 | ₩311,500 | +₩26.6bn | ₩-4.9bn | ₩-25.2bn |
| 2026-08-25 | ₩305,500 | ₩-12.2bn | ₩-22.6bn | +₩34.4bn |
| 2026-08-24 | ₩320,500 | +₩5.7bn | +₩5.0bn | ₩-12.8bn |
| 2026-08-21 | ₩320,000 | ₩-32.0bn | ₩-14.0bn | +₩45.3bn |
| 2026-08-20 | ₩339,500 | +₩53.7bn | +₩59.1bn | ₩-118.5bn |
| 2026-08-19 | ₩303,500 | +₩12.6bn | +₩8.8bn | ₩-22.8bn |
| 2026-08-18 | ₩298,000 | +₩21.9bn | ₩-36.9bn | +₩20.1bn |
| 2026-08-14 | ₩314,000 | +₩8.6bn | ₩-35.5bn | +₩25.6bn |
| 2026-08-13 | ₩317,500 | ₩-21.3bn | ₩-14.6bn | +₩29.2bn |
| 2026-08-12 | ₩317,500 | ₩-2.6bn | ₩-39.5bn | +₩36.5bn |
| 2026-08-11 | ₩327,500 | ₩-48.4bn | ₩-62.3bn | +₩105.8bn |
| 2026-08-10 | ₩348,000 | +₩62.7bn | +₩51.3bn | ₩-114.0bn |
| 2026-08-07 | ₩305,000 | ₩-8.0bn | ₩-3.3bn | +₩9.0bn |
| 2026-08-06 | ₩293,500 | ₩-0.2bn | +₩16.5bn | ₩-17.2bn |
| 2026-08-05 | ₩277,000 | ₩-68.1bn | ₩-43.9bn | +₩109.3bn |
| 2026-08-04 | ₩267,000 | +₩26.1bn | +₩35.4bn | ₩-57.6bn |
| 2026-08-03 | ₩244,301 | ₩-2.8bn | ₩-3.6bn | +₩7.3bn |
| 2026-07-31 | ₩237,376 | +₩28.7bn | ₩-6.1bn | ₩-25.1bn |
| 2026-07-30 | ₩215,062 | +₩10.7bn | ₩-8.2bn | ₩-3.0bn |
| 2026-07-29 | ₩217,370 | ₩-15.2bn | +₩18.1bn | ₩-2.8bn |
| 2026-07-28 | ₩228,143 | ₩-20.2bn | +₩3.4bn | +₩19.8bn |
| 2026-07-27 | ₩240,069 | ₩-17.2bn | +₩33.3bn | ₩-15.9bn |
| 2026-07-24 | ₩231,220 | +₩11.9bn | ₩-4.5bn | ₩-7.3bn |
| 2026-07-23 | ₩235,837 | +₩58.9bn | +₩21.0bn | ₩-81.5bn |
| 2026-07-22 | ₩206,213 | +₩12.8bn | ₩-19.6bn | +₩6.6bn |
| 2026-07-21 | ₩210,061 | +₩16.2bn | +₩9.4bn | ₩-25.1bn |
| 2026-07-20 | ₩207,367 | ₩-2.7bn | ₩-7.7bn | +₩15.3bn |
| 2026-07-16 | ₩212,754 | +₩5.1bn | ₩-14.5bn | +₩9.5bn |
| 2026-07-15 | ₩221,987 | ₩-28.2bn | ₩-44.5bn | +₩71.7bn |
| 2026-07-14 | ₩215,062 | ₩-0.1bn | ₩-38.8bn | +₩38.0bn |
| 2026-07-13 | ₩243,532 | ₩-7.3bn | +₩0.4bn | +₩1.2bn |
Investor flows summary
| Window | Foreign | (USD) | Institutions | Retail |
|---|---|---|---|---|
| 1 day | +₩26.0bn | +$20M | +₩7.5bn | ₩-34.5bn |
| 5 days | +₩42.7bn | +$32M | ₩-8.0bn | ₩-34.6bn |
| 20 days | +₩114.1bn | +$86M | ₩-73.9bn | ₩-33.1bn |
Positive = net buying, negative = net selling. Values aggregate the KRX main board and the NXT alternative venue.
Frequently asked questions
Are foreign investors buying Alteogen stock?
Over the last 5 sessions foreign investors net bought ₩42.7bn ($32M) of Alteogen; over 60 sessions they net bought ₩105.5bn ($79M); since Jan 1, 2026 they net bought ₩216.7bn ($163M). Over 20 sessions the stock is the 4th largest foreign net purchase among 1828 KOSDAQ stocks.
How much of Alteogen do foreign investors own?
Foreign investors own 15.96% of Alteogen's shares as of Oct 13, 2026, versus 13.35% one year earlier. The figure is KRX's daily foreign holdings divided by listed shares, and it reflects trades settled through the previous session.
Who is on the other side — institutions or retail investors?
Over 20 sessions institutions net sold ₩73.9bn ($55M) and retail investors net sold ₩33.1bn ($25M) of Alteogen. Foreign buying is being met mainly by retail selling.
Is Alteogen listed on KOSPI or KOSDAQ?
Alteogen (알테오젠) trades on KOSDAQ under KRX code 196170 in the Biotech & Pharma group, with a market capitalization of ₩16T ($11.7B). Daily net flows by investor type are published by KRX after each session and combine the KRX main board with the NXT venue.
Annual financials
| Fiscal year | Revenue | YoY | Operating profit | Net income |
|---|---|---|---|---|
| 2023 | ₩97bn ($72M) | – | -₩10bn (-$7M) | -₩4bn (-$3M) |
| 2024 | ₩103bn ($77M) | +6.60% | ₩25bn ($19M) | ₩61bn ($46M) |
| 2025 | ₩216bn ($162M) | +109.90% | ₩107bn ($80M) | ₩145bn ($109M) |
Consolidated (K-IFRS) where available, from DART regulatory filings. USD figures converted at the current rate (₩1333.09/$) for reference only.